<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Approach to (Glomerular) Proteinuria</title>
  <style>
    :root {
      --blue: #0073e6;
      --green: #009944;
      --bg: #f4f8fc;
      --dark: #333;
    }
    * { box-sizing: border-box; }
    body {
      margin: 0; padding: 20px;
      font-family: 'Segoe UI', Tahoma, sans-serif;
      background: var(--bg);
      color: var(--dark);
      text-align: center;
    }
    h1 { color: var(--blue); margin-bottom: 1rem; }
    .container {
      display: grid;
      grid-template-columns: 2fr 1fr;
      gap: 1rem;
      max-width: 1200px;
      margin: auto;
    }
    .container2 {
      display: grid;
      grid-template-columns: 1fr;
      gap: 1rem;
      max-width: 1200px;
      margin: auto;
    }
    .container3 {
      display: grid;
      grid-template-columns: 1fr 1fr 1fr;
      gap: 1rem;
      max-width: 1200px;
      margin: auto;
    }
    .box {
      background: #fff;
      border-left: 6px solid var(--blue);
      border-radius: 6px;
      padding: 1rem;
      box-shadow: 0 2px 6px rgba(0,0,0,0.1);
      text-align: left;
      max-width: 1200px;
    }
    .box.green { border-left-color: var(--green); }
    .box h2 { margin-top: 0; color: var(--blue); }
    .box.green h2 { color: var(--green); }
    .box ul { padding-left: 1.2rem; }
    .subbox { display: flex; gap: 1rem; margin-top: 1rem; }
    .subbox .box { flex: 1; border-left-width: 4px; }
    .test {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #ffebeb;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophys {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #ADD8E6;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophysy {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #98f03a;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophyso {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #c6cacf;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophysr {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #f27966;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophysyy {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #abf5ca;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .pathophysp {
      display: inline-block;
      margin: 0.25rem 0.5rem;
      padding: 2px 6px;
      background: #d97df5;
      border: 1px dashed #e60000;
      border-radius: 4px;
      font-size: 0.85em;
    }
    .small-box {
      max-width: 300px;
      margin: 1rem auto;
      border-left: 6px solid var(--blue);
      border-radius: 6px;
      padding: 1rem;
      text-align: left;
      box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
  </style>
</head>
<body>
  <h1>Approach to (Glomerular) Proteinuria</h1>
  

  <div class="container">

    <!-- Nephritic Column -->
    <div class="box">
      <h2>Nephritic Syndrome</h2>
      <h3>Pathophysiology & Clinical Features</h3>
      <ul>
        <li>Inflammation → glomerular damage → renal failure, protein loss, blood loss</li>
        <li>Renal failure:
          <ul>
            <li>↑ BUN & Cr, oliguria</li>
            <li>Hypertension & edema (↑ hydrostatic pressure)</li>
          </ul>
        </li>
        <li>Proteinuria (&lt;3.5 g/day):
          <ul>
            <li>Hypertension & edema (↓ oncotic pressure)</li>
          </ul>
        </li>
        <li>Blood loss:
          <ul>
            <li>Cola-colored urine (melena of GU tract)</li>
            <li>Dysmorphic RBCs</li>
            <li>RBC casts (pathognomonic)</li>
          </ul>
        </li>
      </ul>
      <h3>Diagnosis</h3>
      <ul>
        <li>Initial workup:
          <ul>
            <li>Thorough H&amp;P</li>
            <li>Urinalysis (hematuria, proteinuria)</li>
            <li>BMP (azotemia)</li>
          </ul>
        </li>
        <li>Exclude nephrotic range:
          <ul>
            <li>24-h urine protein</li>
            <li>Urine protein:creatinine ratio</li>
          </ul>
        </li>
        <li>Narrow differential by complement status</li>
        <li>Gold standard: kidney biopsy (EM, IF, LM)</li>
      </ul>
      <h3>Treatment</h3>
      <ul>
        <li>ACE/ARB (symptomatic mgmt for htn)</li>
        <li>Immunosuppression Cornerstone (Except Alport, genetic --> kidney transplant)</li>
      </ul>

      <h3>Nephritis Differential</h3>
      <div class="subbox">
        <div class="box">
          <h3>Low Complement</h3>
          <ul>
            <li><strong>PSGN</strong>:
              nephritis <strong>weeks</strong> post GAS infxn (e.g. impetigo, strep throat); easily confused with IgA nephritis (occurs days URI)
              <div class="pathophys">immune complex</div>
              <div class="test">ASO ↑</div><div class="test">anti-DNase B ↑</div><div class="test">C3 ↓</div>
            </li>
            <li><strong>MPGN</strong>:
              type 1 a/w hep b / c, cryoglobulins. type 2 (dense deposit disease) a/w C3 nephritic factor (stabilizes alternative pathway), 
              LM: "tram-track"
              <div class="pathophys">type 1: immune complex</div><div class="pathophyso">type2: complement dysreg</div>
              <div class="test">C3/C4 ↓</div><div class="test">C3 nephritic factor</div><div class="test">Cryoglobulins</div><div class="test">hep b/c</div>
            </li>
            <li><strong>Lupus Nephritis (DPGN)</strong>:
              a/w lupus; IF: "full-house" (IgG, IgA, IgM, C3, C1q), LM: "wire-loop"
              <div class="pathophys">immune complex</div>
              <div class="test">ANA ↑</div><div class="test">anti-dsDNA ↑</div><div class="test">anti-Smith ↑</div>
            </li>
            <li><strong>Cryoglobulinemic GN</strong>: 
              triad: palpable purpura, polyneuropathy, nephritis; MPGN overlap
              <div class="pathophys">immune complex</div>
              <div class="test">Cryoglobulins +</div><div class="test">C4 ↓</div><div class="test">HCV serology</div>
            </li>
          </ul>
        </div>
        <div class="box green">
          <h3>Normal Complement</h3>
          <ul>
            <li><strong>IgA Nephropathy</strong>: 
              nephritis <strong>days</strong> post GI/URI (mucosal) infection, hsp = extrarenal manifestation, IgA IC do not activate complement
              <div class="pathophys">immune complex</div>
              <div class="test">IgA ↑</div>
            </li>
            <li><strong>ANCA GN</strong>: 
              GPA, eGPA, MPA; IF: negative ("pauci immune" GN)
              <div class="pathophysr">vasculitis</div>
              <div class="test">c-ANCA/PR3</div><div class="test">p-ANCA/MPO</div>
            </li>
            <li><strong>Goodpasture</strong>: 
              hematuria & hemoptysis; IF:linear
              <div class="pathophysy">gbm</div>
              <div class="test">anti-GBM Ab</div>
            </li>
            <li><strong>Alport Syndrome</strong>: 
              type IV collagen defect; triad: hematuria, sensorineural hearing loss, vision problems; tx: renal transplant; EM: "basket weave"
              <div class="pathophysy">gbm</div>
              <div class="test">Genetic testing</div><div class="test">Audiometry</div>
            </li>
          </ul>
        </div>
      </div>
    </div>

    <!-- Nephrotic Column -->
    <div class="box green">
      <h2>Nephrotic Syndrome</h2>
      <h3>Pathophysiology & Clinical Features</h3>
      <ul>
        <li>Glomerular damage → selective protein loss</li>
        <li>Frothy urine (protein = surfactant)</li>
        <li>Ankle/facial edema (albumin loss)</li>
        <li>Hypertension (third spacing → ↓ renal flow → RAAS)</li>
        <li>Hyperlipidemia (>300) → fatty casts/oval fat bodies</li>
        <li>Hypercoagulability (ATIII loss)</li>
        <li>Recurrent infections (IgG loss)</li>
      </ul>
      <h3>Diagnosis</h3>
      <ul>
        <li>Initial workup:
          <ul>
            <li>Urinalysis (proteinuria)* MM may have negative UA</li>
            <li>Lipid panel</li>
            <li>CMP (albumin)</li>
          </ul>
        </li>
        <li>Confirmation:
          <ul>
            <li>24-h urine protein (>3.5 g/day)</li>
            <li>Protein:Cr ratio (>3.5:1)</li>
          </ul>
        </li>
        <li>Gold standard: kidney biopsy (EM, IF, LM)</li>
      </ul>
      <h3>Treatment</h3>
      <ul>
        <li>Statin (hyperlipidemia)</li>
        <li>ACE/ARB (hypertension)</li>
        <li>Sodium restriction (edema)</li>
        <li>Management varies between diseases</li>
      </ul>

      <h3>Nephrosis Differential</h3>
      <ul>
        <li><strong>Minimal Change Disease</strong>: 
          cytokine-mediated podocyte damage (effacement); children, post URI, Hodgkins; steroid responsive
          <div class="pathophysyy">cytokines</div>
        </li>
        <li><strong>FSGS</strong>: 
          cytokine-mediated podocyte damage (effacement); primary - mysterious inflammation; secondary: HIV, heroin, obesity, solitary kidney; steroid unresponsive, tx: risk factor modification, poor prognosis
          <div class="pathophysyy">cytokines</div>
          <div class="test">HIV testing</div><div class="test">UDS</div>
        </li>
        <li><strong>Membranous Nephropathy</strong>: 
          IC deposition -> GBM thickening; lupus, solid tumors, Hep B/C, RA drugs; EM: subepithelial deposits "spike and dome"
          <div class="pathophys">immune complex</div>
          <div class="test">anti-PLA2R</div><div class="test">Hep B/C</div><div class="test">low C3</div><div class="test">ANA ↑</div><div class="test">anti-dsDNA ↑</div><div class="test">anti-Smith ↑</div><div class="test">PET</div>
        </li>
        <li><strong>Diabetic Nephropathy</strong>: 
          non-enzymatic glycation, GBM thickening
          <div class="pathophysp">toxin-mediated</div>
          <div class="test">HbA1c</div><div class="test">Albumin/Cr ratio</div>
        </li>
        <li><strong>Systemic Amyloidosis</strong>: 
          AL (Multiple Myeloma / plasma cell dyscrasia), AA (chronic inflammation e.g. FMF, RA) (kidney & heart (restrictive cardiomyopathy) most commonly affected organs) 
          <div class="pathophysp">toxin-mediated</div>
          <div class="test">SPEP/UPEP</div><div class="test">Congo red</div><div class="test">Fat pad biopsy</div>
        </li>
      </ul>
    </div>

  </div>

  <div class="container2">
    <!-- Key -->
    <div class="box">
        <h3>Key</h3>
        <p><strong>Pathophys</strong> is color coded</p>
        <div class="pathophys">immune complex</div> - most important. glomerular damage due to type III hypersensitivity reaction.
          <div style="padding-left: 2em;">
            --> immunologic insult (e.g. autoimmune, infection) → Ab response → IC formation → glomerular deposition (somewhat random, uneven, therefore IF = "lumpy bumpy" or "granular") → complement activation → glomerular damage
          </div>
        <div class="pathophysy">gbm</div> - glomerular basemement membrane problem. Alport's is genetic, Goodpasture's is Ab mediated<br>
        <div class="pathophyso">toxin-mediated</div> - circulating toxins damage glomerulus<br>
        <div class="pathophysr">vasculitis</div> - small vessel vasculitis damages glomeruli<br>
        <div class="pathophysyy">cytokines</div> - cytokines damage glomeruli (particularly podocyte foot processes), immune response here is notably Ab independent<br>
        <div class="pathophysp">toxin-mediated</div> - amyloid and sugar (in high concentrations) damage glomerulus<br>
        <p><strong>Tests</strong> to consider are green </p>
        <div class="test">think about ordering these tests</div>
    </div>
  </div>

  <div class="container3">
    <!-- RPGN Box -->
    <div class="box">
      <h3>RPGN (Crescentic), Separate Clinical Syndrome</h3>
      <ul>
        <li>Leads to ESRD in months if untreated</li>
        <li>Patients are sick on presentation (AKI, anorexia, fatigue, nephritis)</li>
        <li>Four etiologies below</li>
        <li>Type I: linear (Goodpasture)</li>
        <li>Type II: granular (PSGN, lupus nephritis)</li>
        <li>Type III: pauci-immune (ANCA)</li>
      </ul>
      <p>LM: crescents in bowman's space (hallmark of RPGN)</p>
      <p>Note: PSGN and lupus nephritis rarely progress to RPGN. therefore crescents are commonly absent on LM</p>
      <p>Note: goodpasture and ANCA GN commonly present as RPGN. therefore crescents are commonly present on LM. indolent or subacute disease courses are rare</p>
      <p>Treatment: steroids & cyclophosphamide</p>
    </div>

    <!-- Histopath Derivation -->
    <div class="box">
      <h3>Histopath Derivation</h3>
      <ul>
        <li>“Membranous”: EM: subepithelial deposits; LM: basement membrane thickening</li>
        <li>“Proliferative”: LM: mesangial hypercellularity;</li>
        <li>if pathophys = immune complex --> IF: granular, lumpy bumpy</li>
      </ul>
    </div>

    <!-- Buzzword Compilation -->
    <div class="box green">
      <h3>Buzzword Compilation</h3>
      <ul>
        <li>RPGN - "crescentic"</li>
        <li>MPGN - "tram track"</li>
        <li>DPGN - "wire-loop", "full house"</li>
        <li>ANCA - "pauci-immune"</li>
        <li>Alport - "basket-weave"</li>
        <li>Membranous - "spike and dome"</li>
        <li>Amyloid - "apple-green birefringence"</li>
      </ul>
    </div>
  </div>

  <div class="container2">
    <div class="box">
      <h3><strong>DO NOT MEMORIZE THIS SHIT, WASTE OF TIME, HERE FOR FUN</strong></h3>
      <table style="width:100%; border-collapse: collapse; text-align: left; font-size: 0.95em;">
        <thead style="background-color: #f0f0f0;">
          <tr>
            <th style="padding: 8px; border-bottom: 1px solid #ccc;">Disease</th>
            <th style="padding: 8px; border-bottom: 1px solid #ccc;">EM</th>
            <th style="padding: 8px; border-bottom: 1px solid #ccc;">IF</th>
            <th style="padding: 8px; border-bottom: 1px solid #ccc;">LM</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td style="padding: 8px;">PSGN</td>
            <td style="padding: 8px;">Subepithelial humps</td>
            <td style="padding: 8px;">Granular ("lumpy bumpy")</td>
            <td style="padding: 8px;">Hypercellular glomeruli, neutrophils, (if progresses to RPGN, will show crescents in bowman's space)</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Lupus Nephritis (DPGN)</td>
            <td style="padding: 8px;">Subendothelial ± mesangial deposits</td>
            <td style="padding: 8px;">"Full house" (IgG, IgA, IgM, C3, C1q)</td>
            <td style="padding: 8px;">Wire-loop lesions, diffuse hypercellularity, (if progresses to RPGN, will show crescents in bowman's space)</td>
          </tr>
          <tr>
            <td style="padding: 8px;">MPGN</td>
            <td style="padding: 8px;">Type I: Subendothelial, Type II: Dense deposits</td>
            <td style="padding: 8px;">Granular (Type I), C3 only (Type II)</td>
            <td style="padding: 8px;">Mesangial hypercellularity, GBM splitting ("tram-track")</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Goodpasture</td>
            <td style="padding: 8px;">No immune deposits</td>
            <td style="padding: 8px;">Linear IgG along GBM</td>
            <td style="padding: 8px;">Crescentic GN</td>
          </tr>
          <tr>
            <td style="padding: 8px;">ANCA Vasculitis (e.g., GPA, MPA)</td>
            <td style="padding: 8px;">No immune deposits</td>
            <td style="padding: 8px;">Negative (pauci-immune)</td>
            <td style="padding: 8px;">Crescentic GN, necrosis</td>
          </tr>
          <tr>
            <td style="padding: 8px;">IgA Nephropathy</td>
            <td style="padding: 8px;">Mesangial deposits</td>
            <td style="padding: 8px;">IgA in mesangium</td>
            <td style="padding: 8px;">Mesangial proliferation</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Alport Syndrome</td>
            <td style="padding: 8px;">Irregular thickening/thinning, basket-weave appearance</td>
            <td style="padding: 8px;">Negative</td>
            <td style="padding: 8px;">Variable, often nonspecific</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Membranous Nephropathy</td>
            <td style="padding: 8px;">Subepithelial deposits ("spike & dome")</td>
            <td style="padding: 8px;">Granular IgG and C3</td>
            <td style="padding: 8px;">Diffuse GBM thickening, no hypercellularity</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Minimal Change Disease</td>
            <td style="padding: 8px;">Effacement of foot processes</td>
            <td style="padding: 8px;">Negative</td>
            <td style="padding: 8px;">Normal glomeruli</td>
          </tr>
          <tr>
            <td style="padding: 8px;">FSGS</td>
            <td style="padding: 8px;">Foot process effacement (segmental)</td>
            <td style="padding: 8px;">Negative or nonspecific</td>
            <td style="padding: 8px;">Segmental sclerosis, focal distribution</td>
          </tr>
          <tr>
            <td style="padding: 8px;">Amyloidosis</td>
            <td style="padding: 8px;">Non-branching fibrils (10 nm)</td>
            <td style="padding: 8px;">Apple-green birefringence with Congo red</td>
            <td style="padding: 8px;">Amorphous hyaline material in mesangium</td>
          </tr>
        </tbody>
      </table>
    </div>
  </div>


</body>
</html>

